NCT04034329

Brief Summary

This study will be looking at the effect of Ambulatory Selective Varices Ablation under Local Anesthesia (ASVAL) and Endovenous Laser Ablation (EVLA) with concomitant phlebectomy in patients with incompetent great saphenous vein (GSV).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
6.6 years until next milestone

First Submitted

Initial submission to the registry

July 23, 2019

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 26, 2019

Completed
5.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

February 10, 2023

Status Verified

February 1, 2023

Enrollment Period

6.6 years

First QC Date

July 23, 2019

Last Update Submit

February 9, 2023

Conditions

Keywords

ASVALEVLAGSVLong-term efficacy

Outcome Measures

Primary Outcomes (10)

  • Number of Participants with pain or other discomfort (ie aching, heaviness, fatigue, soreness, burning) from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, interfering with, but not preventing regular daily activities (2), Daily limiting most regular daily activities (3)

    2-5 years

  • Number of Participants with varicose Veins from absent (score 0) to severe (score 3).

    None (0), Few, scattered (1), Confined to calf or thigh (2) Involve calf and thigh (3)

    2-5 years

  • Number of Participants with venous oedema from absent (score 0) to severe (score 3).

    None (0) Limited to foot or ankle (1), Extends above ankle but below knee (2), Extends to knee or above (3)

    2-5 years

  • Number of Participants with skin Pigmentation from absent (score 0) to severe (score 3).

    None (0), Limited to perimalleolar area (1), Diffuse over lower third of calf (2), Wider distribution (above lower third of calf) (3)

    2-5 years

  • Number of Participants with inflammation from absent (score 0) to severe (score 3).

    None (0), Limited to perimalleolar area (1), Diffuse over lower third of calf (2), Wider distribution (above lower third of calf) (3)

    2-5 years

  • Number of Participants with induration from absent (score 0) to severe (score 3).

    None (0), Limited to perimalleolar area (1), Involving lower third of calf (2), Involving more than lower third of calf (3)

    2-5 years

  • Number of Participants with active ulcers from absent (score 0) to severe (score 3).

    None (0), 1 (1), 2 (2), more than 2 (3)

    2-5 years

  • Number of Participants with different duration of active ulcer: from absent (score 0) to severe (score 3).

    None (0), Less than 3 months (1), More than 3 months but less than 1 year (2) More than 1year (3)

    2-5 years

  • Number of Participants with active ulcer diameter from absent (score 0) to severe (score 3).

    None (0), Diameter less than 2 cm (1), Diameter 2-6 cm (2), Diameter more than 6 cm (3)

    2-5 years

  • Number of Participants with compression therapy from absent (score 0) to severe (score 3).

    Not used (0), Intermittent use of stockings (1), Uses stockings most days (2), Full compliance with stockings (3)

    2-5 years

Secondary Outcomes (1)

  • Number of Participants with clinical recurrence-free rate (no - score 0, yes - score 1)

    2-5 years

Study Arms (2)

ASVAL - group

GSV diameter ≤ 6 mm

Procedure: ASVAL

EVLA-group

GSV diameter \> 6 mm

Procedure: EVLA

Interventions

ASVALPROCEDURE

Ambulatory Selective Varices Ablation under Local Anesthesia

ASVAL - group
EVLAPROCEDURE

Endovenous Laser Ablation

EVLA-group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with GSV incompetence and C2-C3 were included in the prospective consecutive case study if they satisfied the selection criteria

You may qualify if:

  • Great saphenous vein (GSV) incompetence with reflux at least down to the knee level
  • Primary symptomatic varicose veins, Clinical Etiological Anatomical Pathophysiological (CEAP) classification, clinical class C2-C3
  • Physical status according to American Society of Anesthesiologists (ASA) I-II (I-Healthy, non-smoking, no or minimal alcohol use; II-Mild diseases only without substantive functional limitations)

You may not qualify if:

  • Previous surgical groin exploration, except herniotomy
  • Small saphenous vein, anterior or posterior accessory saphenous vein incompetence at the same limb
  • Deep venous thrombosis, thrombophilia associated with a high risk of deep venous thrombosis or postthrombotic syndrome
  • Arterial occlusive disease more severe than Intermittent claudication after more than 200 meters of pain free walking (Fontaine IIA) and/or ankle brachial index below 0.8

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Educational Institution"Belarusian State Medical University"

Minsk, Dzerzhinski Ave., 83, 220116, Belarus

Location

Related Publications (7)

  • Pittaluga P, Chastanet S. Persistent incompetent truncal veins should not be treated immediately. Phlebology. 2015 Mar;30(1 Suppl):98-106. doi: 10.1177/0268355515569141.

    PMID: 25729076BACKGROUND
  • Chastanet S, Pittaluga P. Influence of the competence of the sapheno-femoral junction on the mode of treatment of varicose veins by surgery. Phlebology. 2014 May;29(1 suppl):61-65. doi: 10.1177/0268355514529207. Epub 2014 May 19.

    PMID: 24843088BACKGROUND
  • van Neer P, Kessels FG, Estourgie RJ, de Haan EF, Neumann MA, Veraart JC. Persistent reflux below the knee after stripping of the great saphenous vein. J Vasc Surg. 2009 Oct;50(4):831-4. doi: 10.1016/j.jvs.2009.05.021. Epub 2009 Jul 12.

    PMID: 19595549BACKGROUND
  • Zolotukhin IA, Seliverstov EI, Zakharova EA, Kirienko AI. Short-term results of isolated phlebectomy with preservation of incompetent great saphenous vein (ASVAL procedure) in primary varicose veins disease. Phlebology. 2017 Oct;32(9):601-607. doi: 10.1177/0268355516674415. Epub 2016 Oct 19.

    PMID: 27760806BACKGROUND
  • Harlander-Locke M, Jimenez JC, Lawrence PF, Derubertis BG, Rigberg DA, Gelabert HA. Endovenous ablation with concomitant phlebectomy is a safe and effective method of treatment for symptomatic patients with axial reflux and large incompetent tributaries. J Vasc Surg. 2013 Jul;58(1):166-72. doi: 10.1016/j.jvs.2012.12.054. Epub 2013 Apr 6.

    PMID: 23571079BACKGROUND
  • Puggioni A, Kalra M, Carmo M, Mozes G, Gloviczki P. Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications. J Vasc Surg. 2005 Sep;42(3):488-93. doi: 10.1016/j.jvs.2005.05.014.

    PMID: 16171593BACKGROUND
  • Nesbitt C, Bedenis R, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev. 2014 Jul 30;(7):CD005624. doi: 10.1002/14651858.CD005624.pub3.

    PMID: 25075589BACKGROUND

MeSH Terms

Conditions

Varicose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Genadz Kandratsenka, Prof

    Educational Institution"Belarusian State Medical University"

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 23, 2019

First Posted

July 26, 2019

Study Start

January 1, 2013

Primary Completion

July 23, 2019

Study Completion

February 1, 2025

Last Updated

February 10, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

To compare clinical efficacy of Ambulatory Selective Varices Ablation under Local Anesthesia (ASVAL) and Endovenous Laser Ablation (EVLA) with concomitant phlebectomy in patients with incompetent great saphenous vein (GSV).

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
01.2020
Access Criteria
To compare clinical efficacy of Ambulatory Selective Varices Ablation under Local Anesthesia (ASVAL) and Endovenous Laser Ablation (EVLA) with concomitant phlebectomy in patients with incompetent great saphenous vein (GSV).

Locations